2022-Ra-653-Esgo The Impact of Histology, Prior Therapy, and Dmmr Status on Lenvatinib + Pembrolizumab Outcomes in Patients with Advanced Endometrial Cancer: A Subgroup Analysis of Study 309/Keynote-775

AuthID
 P-00Y-VYM
20
Author(s)
Lorusso, D
·
Makker, V
·
Herraez, AC
·
Monk, BJ
·
Mackay, H
·
Santin, AD
·
Moore, R
·
Baron-Hay, S
·
Ray-Coquard, I
·
Shapira-Frommer, R
·
Ushijima, K
·
Yonemori, K
·
Kim, YM
·
Guerra Alia, EM
·
Sanli, UA
·
Huang, J
·
McKenzie, J
·
Barresi, G
·
Colombo, N
Tipo de Documento
Proceedings Paper
Year published
2022
Publicado
in Endometrial cancer
Indexing
Crossref®1
Google Scholar®
Publication Identifiers
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service